Literature DB >> 27627661

Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to 1H CPMG Ligand-Observed NMR.

Andrew K Urick1,2, Luis Pablo Calle3, Juan F Espinosa3, Haitao Hu2, William C K Pomerantz1.   

Abstract

To evaluate its potential as a ligand discovery tool, we compare a newly developed 1D protein-observed fluorine NMR (PrOF NMR) screening method with the well-characterized ligand-observed 1H CPMG NMR screen. We selected the first bromodomain of Brd4 as a model system to benchmark PrOF NMR because of the high ligandability of Brd4 and the need for small molecule inhibitors of related epigenetic regulatory proteins. We compare the two methods' hit sensitivity, triaging ability, experiment speed, material consumption, and the potential for false positives and negatives. To this end, we screened 930 fragment molecules against Brd4 in mixtures of five and followed up these studies with mixture deconvolution and affinity characterization of the top hits. In selected examples, we also compare the environmental responsiveness of the 19F chemical shift to 1H in 1D-protein observed 1H NMR experiments. To address concerns of perturbations from fluorine incorporation, ligand binding trends and affinities were verified via thermal shift assays and isothermal titration calorimetry. We conclude that for the protein understudy here, PrOF NMR and 1H CPMG have similar sensitivity, with both being effective tools for ligand discovery. In cases where an unlabeled protein can be used, 1D protein-observed 1H NMR may also be effective; however, the 19F chemical shift remains significantly more responsive.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27627661      PMCID: PMC8325173          DOI: 10.1021/acschembio.6b00730

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  52 in total

1.  Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand.

Authors:  Xinyi Huang
Journal:  J Biomol Screen       Date:  2003-02

2.  Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery.

Authors:  Chun-Wa Chung; Anthony W Dean; James M Woolven; Paul Bamborough
Journal:  J Med Chem       Date:  2012-01-11       Impact factor: 7.446

3.  New method for fast and accurate binding-site identification and analysis.

Authors:  Tom Halgren
Journal:  Chem Biol Drug Des       Date:  2007-02       Impact factor: 2.817

Review 4.  A decade of fragment-based drug design: strategic advances and lessons learned.

Authors:  Philip J Hajduk; Jonathan Greer
Journal:  Nat Rev Drug Discov       Date:  2007-02-09       Impact factor: 84.694

5.  Identifying and characterizing binding sites and assessing druggability.

Authors:  Thomas A Halgren
Journal:  J Chem Inf Model       Date:  2009-02       Impact factor: 4.956

Review 6.  Fragment screening by SPR and advanced application to GPCRs.

Authors:  Claire A Shepherd; Andrew L Hopkins; Iva Navratilova
Journal:  Prog Biophys Mol Biol       Date:  2014-10-06       Impact factor: 3.667

7.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

8.  Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold.

Authors:  Shane M Devine; Mark D Mulcair; Cael O Debono; Eleanor W W Leung; J Willem M Nissink; San Sui Lim; Indu R Chandrashekaran; Mansha Vazirani; Biswaranjan Mohanty; Jamie S Simpson; Jonathan B Baell; Peter J Scammells; Raymond S Norton; Martin J Scanlon
Journal:  J Med Chem       Date:  2015-01-16       Impact factor: 7.446

9.  Simple and inexpensive incorporation of 19F-tryptophan for protein NMR spectroscopy.

Authors:  Peter B Crowley; Ciara Kyne; William B Monteith
Journal:  Chem Commun (Camb)       Date:  2012-11-07       Impact factor: 6.222

10.  Pharmacological manipulation of transcription factor protein-protein interactions: opportunities and obstacles.

Authors:  Frank Fontaine; Jeroen Overman; Mathias François
Journal:  Cell Regen (Lond)       Date:  2015-03-12
View more
  15 in total

1.  Specific Acetylation Patterns of H2A.Z Form Transient Interactions with the BPTF Bromodomain.

Authors:  Gabriella T Perell; Neeraj K Mishra; Babu Sudhamalla; Peter D Ycas; Kabirul Islam; William C K Pomerantz
Journal:  Biochemistry       Date:  2017-08-23       Impact factor: 3.162

2.  NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex.

Authors:  Noelle M Olson; Samantha Kroc; Jorden A Johnson; Huda Zahid; Peter D Ycas; Alice Chan; Jennifer R Kimbrough; Prakriti Kalra; Ernst Schönbrunn; William C K Pomerantz
Journal:  Biochemistry       Date:  2020-05-11       Impact factor: 3.162

3.  Evaluating the Advantages of Using 3D-Enriched Fragments for Targeting BET Bromodomains.

Authors:  Jorden A Johnson; Christos A Nicolaou; Steven E Kirberger; Anil K Pandey; Haitao Hu; William C K Pomerantz
Journal:  ACS Med Chem Lett       Date:  2019-11-22       Impact factor: 4.345

4.  New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development.

Authors:  Peter D Ycas; Huda Zahid; Alice Chan; Noelle M Olson; Jorden A Johnson; Siva K Talluri; Ernst Schonbrunn; William C K Pomerantz
Journal:  Org Biomol Chem       Date:  2020-07-15       Impact factor: 3.876

5.  Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α.

Authors:  James N Ingle; Junmei Cairns; Vera J Suman; Lois E Shepherd; Peter A Fasching; Tanya L Hoskin; Ravinder J Singh; Zeruesenay Desta; Krishna R Kalari; Matthew J Ellis; Paul E Goss; Bingshu E Chen; Bernhard Volz; Poulami Barman; Erin E Carlson; Tufia Haddad; Matthew P Goetz; Barbara Goodnature; Matthew E Cuellar; Michael A Walters; Cristina Correia; Scott H Kaufmann; Richard M Weinshilboum; Liewei Wang
Journal:  Clin Cancer Res       Date:  2020-02-25       Impact factor: 12.531

6.  Meeting Proceedings ICBS2016-Translating the Power of Chemical Biology to Clinical Advances.

Authors:  Yugo Kuriki; Toru Komatsu; Peter D Ycas; Sara K Coulup; Erick J Carlson; William C K Pomerantz
Journal:  ACS Chem Biol       Date:  2017-03-17       Impact factor: 5.100

7.  Selective Radical Trifluoromethylation of Native Residues in Proteins.

Authors:  Mateusz Imiołek; Gogulan Karunanithy; Wai-Lung Ng; Andrew J Baldwin; Véronique Gouverneur; Benjamin G Davis
Journal:  J Am Chem Soc       Date:  2018-01-22       Impact factor: 15.419

8.  The Biophysical Probes 2-fluorohistidine and 4-fluorohistidine: Spectroscopic Signatures and Molecular Properties.

Authors:  Chandana Kasireddy; Jonathan M Ellis; James G Bann; Katie R Mitchell-Koch
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

9.  Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor.

Authors:  Steven E Kirberger; Peter D Ycas; Jorden A Johnson; Chen Chen; Michael F Ciccone; Rinette W L Woo; Andrew K Urick; Huda Zahid; Ke Shi; Hideki Aihara; Sean D McAllister; Mohammed Kashani-Sabet; Junwei Shi; Alex Dickson; Camila O Dos Santos; William C K Pomerantz
Journal:  Org Biomol Chem       Date:  2019-02-13       Impact factor: 3.890

Review 10.  NMR-Fragment Based Virtual Screening: A Brief Overview.

Authors:  Meenakshi Singh; Benjamin Tam; Barak Akabayov
Journal:  Molecules       Date:  2018-01-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.